UBS O'Connor’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,428,122
| Closed | -$813M | – | 1048 |
|
|
2021
Q2 | $813M | Buy |
4,428,122
+2,861,349
| +183% | +$526M | 7.26% | 2 |
|
|
2021
Q1 | $240M | Buy |
1,566,773
+1,017,152
| +185% | +$156M | 3.45% | 6 |
|
|
2020
Q4 | $85.9M | Buy |
+549,621
| New | +$85.9M | 1.75% | 9 |
|
|
2016
Q2 | – | Sell |
-10,010
| Closed | -$1.39M | – | 490 |
|
|
2016
Q1 | $1.39M | Buy |
+10,010
| New | +$1.39M | 0.03% | 288 |
|